Risk of Clinically Significant Graft-Versus-Host Disease (CSGVHD) in Children Receiving Allogeneic Hematopoietic Cell Transplant (HCT) for Non-Malignant Disorders in Florida (2010-2019)
2021
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI